Logo

American Heart Association

  15
  0


Final ID: MP2046

Symptoms of Bladder Incontinence Are Associated with Worse Functional Status and Quality of Life in Heart Failure with Preserved Ejection Fraction

Abstract Body (Do not enter title and authors here): Introduction
Heart failure with preserved ejection fraction (HFpEF) is a geriatric syndrome characterized by a high burden of frailty, sarcopenia, and physical dysfunction. Given this clinical phenotype, patients with HFpEF would be anticipated to demonstrate elevated rates of incontinence; however, the prevalence and burden of bladder symptoms in this population and their associations with quality of life and physical function remain poorly characterized.
Methods
This single-center study included patients enrolled in a prospective HFpEF registry at UT Southwestern between 8/2023-5/2025. Participants completed the Bladder Condition Assessment Tool (BCAT), a 4-item questionnaire that ranges from 0 to 20, with higher scores indicating more severe symptoms of incontinence. Outcomes included health-related quality of life (Kansas City Cardiomyopathy Questionnaire [KCCQ-12]), physical function (Short Physical Performance Battery [SPPB]), 6-minute walk distance (6MWD), and frailty (Fried Frailty Scale). Participants were stratified by data-derived BCAT tertiles representing minimal (tertile 1), intermediate (tertile 2), and severe (tertile 3) symptoms of incontinence. Linear regression assessed unadjusted associations between BCAT scores and outcomes, with additional adjustment for age, sex, and BMI.
Results
193 participants (age 70±12 years; 77% female; 29% Black) were included. The median (IQR) BCAT scores for the minimal, intermediate, and severe symptom groups were 3 (2-4), 7 (6-9), and 13 (11-15), respectively. Across symptom severity groups, there were no significant differences in age, sex, race, or comorbidities, though BMI was higher with greater symptom severity (p=0.042). In unadjusted analysis, severe (vs minimal/intermediate) symptoms were associated with worse 6MWD (β: -70 m; p=0.002), KCCQ-12 scores (β: -11; p=0.011), frailty (β: 0.52; p=0.005), and SPPB (β: -1.3; p=0.015). After adjustment, severe (vs minimal/intermediate) symptoms remained significantly associated with worse 6MWD (aβ: -50 m; p=0.022), KCCQ-12 scores (aβ: -9.0; p=0.036), and frailty (aβ: 0.46; p=0.016), with a trend towards worse SPPB Score (aβ: -0.92; p=0.075).
Discussion
Worse symptoms of incontinence were associated with poorer physical function, decreased quality of life, and greater frailty. Given the substantial burden of symptoms in this population, clinicians should assess for incontinence as part of comprehensive HFpEF care.
  • Jain, Anand  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Pandey, Ambarish  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Keshvani, Neil  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Chandra, Alvin  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Subramanian, Vinayak  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Patel, Lajjaben  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Shah, Sophia  ( Sarfez Pharmaceuticals , Vienna , Virginia , United States )
  • Shah, Salim  ( Sarfez Pharmaceuticals , Vienna , Virginia , United States )
  • Wilcox, Christopher  ( Georgetown University , Washington , District of Columbia , United States )
  • Pitt, Bertram  ( University of Michigan Medical School , Ann Arbor , Michigan , United States )
  • Author Disclosures:
    Anand Jain: DO NOT have relevant financial relationships | Ambarish Pandey: DO have relevant financial relationships ; Consultant:Tricog:Active (exists now) ; Consultant:Sarfez Therapeutics, Edwards Lifesciences, Merck, Bayer, Anumana, Alleviant, Pfizer, Abbott, Axon Therapies, Kilele Health, Acorai, Kardigan, Novartis, Idorsia Pharma, and Science37:Active (exists now) ; Consultant:Rivus:Active (exists now) ; Consultant:iRhythm:Active (exists now) ; Researcher:SQ innovations:Active (exists now) ; Research Funding (PI or named investigator):SC Pharma:Active (exists now) ; Consultant:Astra Zeneca:Active (exists now) ; Research Funding (PI or named investigator):Ultromics:Active (exists now) ; Research Funding (PI or named investigator):Roche:Active (exists now) ; Consultant:Ultromics:Active (exists now) ; Consultant:Roche:Active (exists now) ; Consultant:Lilly:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) | Neil Keshvani: DO have relevant financial relationships ; Consultant:Science37:Active (exists now) ; Consultant:Idorsia Pharmaceuticals:Past (completed) ; Consultant:Tricog Health, Inc:Past (completed) | Alvin Chandra: DO have relevant financial relationships ; Research Funding (PI or named investigator):Novo Nordisk:Active (exists now) | Vinayak Subramanian: DO NOT have relevant financial relationships | Lajjaben Patel: No Answer | Sophia Shah: No Answer | Salim Shah: No Answer | Christopher Wilcox: No Answer | Bertram Pitt: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Heart Failure and Cardiomyopathy: Disease Management and Outcomes

Monday, 11/10/2025 , 12:15PM - 01:10PM

Moderated Digital Poster Session

More abstracts on this topic:
Predictive Model and Factors for Out-of-Hospital Cardiac Arrest in Geriatric Patients with insomnia: A Longitudinal Study

Chen Chi-hsin, Sung Chih-wei, Chih Yun-ting, Huang Edward Pei-chuan

A Recalled Experience of Death Among Cardiac Arrest Survivors Is Associated with Improved Psychological Outcomes

Goins Imani, Ingram Cambell, Wei Lijing, Gonzales Anelly, He Tun, Moore Sacha, Parnia Sam

More abstracts from these authors:
Clinical and Hemodynamic Correlates of Supranormal Ejection Fraction in Heart Failure with Preserved Ejection Fraction (HFpEF)

Dhruve Ritika, Koshy Thomas, Pandey Ambarish, Patel Lajjaben, Subramanian Vinayak, Segar Matthew, Miller James, Lokesh Nidhish, Keshvani Neil, Tong Dan, Chandra Alvin

A Polypill Strategy for Heart Failure with Reduced Ejection Fraction: The POLY-HF Trial

Pandey Ambarish, Wang Thomas, Keshvani Neil, Rizvi Syed Kazim, Jain Anand, Coellar Juan David, Drazner Mark, Gupta Deepak, Chandra Alvin, Zaha Vlad

You have to be authorized to contact abstract author. Please, Login
Not Available